Company Filing History:
Years Active: 2021-2024
Title: Michael Levandoski: Innovator in Proteomic Genotyping
Introduction
Michael Levandoski is a notable inventor based in Hillsborough, NC (US). He has made significant contributions to the field of proteomic genotyping, holding two patents that showcase his innovative work. His expertise in liquid chromatography and mass spectrometry has paved the way for advancements in genetic analysis.
Latest Patents
Levandoski's latest patents include methods and systems for LC-MS/MS proteomic genotyping. These patents disclose innovative techniques using liquid chromatography/tandem mass spectrometry (LC-MS/MS and 2D-LC-MS/MS) for the proteomic analysis of genotypes. In certain embodiments, the samples used in the analysis comprise dried bodily fluids, highlighting the practical applications of his work in real-world scenarios.
Career Highlights
Michael Levandoski is currently associated with Laboratory Corporation of America Holdings, where he continues to push the boundaries of scientific research and innovation. His work has been instrumental in enhancing the understanding of proteomic analysis and its implications in various fields.
Collaborations
Throughout his career, Levandoski has collaborated with esteemed colleagues, including Christopher Michael Shuford and Russell Philip Grant. These partnerships have fostered a collaborative environment that encourages the exchange of ideas and advancements in research.
Conclusion
Michael Levandoski's contributions to proteomic genotyping through his innovative patents and collaborations underscore his importance in the field. His work continues to influence advancements in genetic analysis and showcases the potential of scientific innovation.